EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $150,000 | -29.6% | 18,450 | -17.0% | 0.01% | -30.0% |
| Q2 2020 | $213,000 | +100.9% | 22,226 | +42.5% | 0.02% | +53.8% |
| Q1 2020 | $106,000 | -38.7% | 15,592 | +34.5% | 0.01% | -13.3% |
| Q4 2019 | $173,000 | +44.2% | 11,592 | -1.3% | 0.02% | +25.0% |
| Q3 2019 | $120,000 | -7.7% | 11,742 | -4.5% | 0.01% | -7.7% |
| Q2 2019 | $130,000 | -27.4% | 12,292 | -3.9% | 0.01% | -31.6% |
| Q1 2019 | $179,000 | -6.3% | 12,792 | -33.9% | 0.02% | -24.0% |
| Q1 2018 | $191,000 | +67.5% | 19,350 | +87.0% | 0.02% | +66.7% |
| Q3 2017 | $114,000 | – | 10,350 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |